INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "TUMOR-TARGETED SPLIT IL2 RECEPTOR AGONISTS"

GENEVA, Feb. 24 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/042275) for "TUMOR-TARGETED SPLIT IL2 RECEPTOR AGONISTS" on Aug 15, 2025. With publication no. WO/2026/039791, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Jiaxi (c/o Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River RoadTarrytown, New York 10591), PATEL, Supriya (c/o Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River RoadTarrytown, New York 10591), GARG, Vidur ...